New Results

COVID-19: A need for new rather than repurposed antiviral drugs

Dory Kovacs, Chris Davis, Paul Cannon, Melanie McFarlane, Stephanie M Rainey, Rute Pinto, Meredith E Stewart, Agnieszka M Szemiel, Aislynn Taggart, Alain Kohl, Fiona Marra, Emma C Thomson, Janet T Scott
doi: https://doi.org/10.1101/2021.03.25.436935

Article usage

Article usage: March 2021 to November 2024

AbstractFullPdf
Mar 202140622190
Apr 202124637129
May 20211531596
Jun 202160777
Jul 202169444
Aug 202149519
Sep 202149126
Oct 2021302103
Nov 202148814
Dec 20213819
Jan 20222626
Feb 20221749
Mar 202225012
Apr 20222618
May 202238215
Jun 20223306
Jul 202249135
Aug 202224013
Sep 20222409
Oct 20223105
Nov 202233112
Dec 20221449
Jan 2023221313
Feb 202313210
Mar 20231229
Apr 20231102
May 202318113
Jun 20231228
Jul 20231028
Aug 20231627
Sep 202317015
Oct 202324111
Nov 20232364
Dec 20232437
Jan 202422013
Feb 20241105
Mar 202417214
Apr 202411013
May 20242218
Jun 20241933
Jul 20249336
Aug 20242127
Sep 202412214
Oct 20241469
Nov 20241417
Back to top
Posted March 25, 2021.
Download PDF
Email
COVID-19: A need for new rather than repurposed antiviral drugs
Dory Kovacs, Chris Davis, Paul Cannon, Melanie McFarlane, Stephanie M Rainey, Rute Pinto, Meredith E Stewart, Agnieszka M Szemiel, Aislynn Taggart, Alain Kohl, Fiona Marra, Emma C Thomson, Janet T Scott
bioRxiv 2021.03.25.436935; doi: https://doi.org/10.1101/2021.03.25.436935
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area